| |
| |
|
| Insider
Information: |
Culley Brian M |
| Relationship: |
President and CEO, Dir... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
204,342 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$281,590 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
204,342 |
|
|
| Total
Value |
$281,590 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savara Inc |
SVRA |
CEO and Director, Dire... |
2012-03-14 |
34,500 |
2010-05-27 |
0 |
Premium* |
|
|
Inksure Technologies Inc |
INKS |
Chief Executive Officer |
2017-10-23 |
25,000 |
2017-10-23 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
President and CEO, Dir... |
2024-02-11 |
144,842 |
2019-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INKS |
Inksure Technologies Inc |
Chief Executive Officer |
• – – |
2017-10-23 |
4 |
B |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
2.66 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-09-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
61,800 |
146,331 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
140,410 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
150,517 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2021-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
71,266 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
81,373 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2022-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
96,730 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,450 |
113,237 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,249 |
139,143 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2024-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,249 |
157,648 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2020-03-31 |
4 |
D |
$0.83 |
$4,425 |
D/D |
(5,343) |
155,281 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2020-06-30 |
4 |
D |
$0.87 |
$4,648 |
D/D |
(5,343) |
165,388 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-12-31 |
4 |
D |
$0.89 |
$4,755 |
D/D |
(5,343) |
145,174 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2020-09-30 |
4 |
D |
$0.94 |
$5,004 |
D/D |
(5,343) |
175,495 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-09-30 |
4 |
D |
$0.98 |
$5,236 |
D/D |
(5,343) |
135,067 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2022-03-25 |
4 |
B |
$1.38 |
$7,245 |
D/D |
5,250 |
81,280 |
2.81 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2022-03-31 |
4 |
D |
$1.54 |
$8,228 |
D/D |
(5,343) |
91,387 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2022-06-30 |
4 |
D |
$1.58 |
$8,442 |
D/D |
(5,343) |
107,894 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2020-12-31 |
4 |
D |
$1.76 |
$9,404 |
D/D |
(5,343) |
185,602 |
0 |
- |
|
| SVRA |
Savara Inc |
Chief Executive Officer |
• – – |
2010-05-27 |
4 |
B |
$1.89 |
$9,450 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2022-03-31 |
4 |
B |
$1.53 |
$9,792 |
D/D |
6,400 |
97,787 |
2.81 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
President and CEO |
• • – |
2019-08-13 |
4 |
B |
$1.01 |
$10,100 |
D/D |
10,000 |
84,531 |
2.81 |
- |
|
| SVRA |
Savara Inc |
CEO and Director |
• • – |
2012-03-14 |
4 |
B |
$0.59 |
$12,103 |
D/D |
20,500 |
34,500 |
2.81 |
- |
|
| SVRA |
Savara Inc |
Chief Executive Officer |
• – – |
2011-06-02 |
4 |
AS |
$2.44 |
$12,200 |
D/D |
(5,000) |
0 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
